Ana Patacão - Executive Director, Real World Evidence & Late Phase
Ana Patacão came to CTI in 2017 with the acquisition of Eurotrials, where she had worked for 6 years, beginning as a Lead CRA and progressing in her career to perform various roles including Clinical Data Business Unit Manager and Regulatory and Data Sciences Global Director. Upon integrating into CTI, Ana was appointed to the role of Senior Director, Real World & Late Phase. Ana will continue to provide mentorship and guidance for her team and be responsible for Real World Evidence operations across Europe and Latin America.
"We are thrilled to announce Ana's promotion," remarks Lynn Fallon, president of CTI. "Ana consistently adds value in all her interactions, both internally and with our partners, and we look forward to her continued contributions and successes."